This online event is jointly hosted by the World Bank, Joint Learning Network and Global Financing Facility and features CGD Director of Global Health Policy Dr. Kalipso Chalkidou and her colleagues, Dr. Carleigh Krubiner and Dr. Y-Ling Chi.
Join using Webex. Meeting number: 160 951 6622, Meeting password: mnVArZtN863
Since the beginning of the COVID-19 outbreak, many health-related policy decisions have relied on epidemiologic models with a near singular focus on COVID-19 cases and deaths. Collateral health effects of COVID-19 (for example disruptions of health supply chains or avoidance of care from patients) are complex and costly both in terms of their personal and financial toll, but are completely predictable and should be addressed early to avoid adding to already growing COVID-19 deaths.
This roundtable discussion, organized by the Efficiency Collaborative of the JLN, aims to learn from countries about their efforts to monitor, mitigate, and finance strategies to manage collateral health effects of COVID-19. The discussion will open with the brief presentation of a framework to map and diagnose these effects, plus the presentation of specific country examples, including India’s efforts to minimize harm for cancer patients in the COVID-19 outbreak. This will be followed by a moderated roundtable discussion inviting participants to share their country experience and views on the following questions:
What indirect health effects are you observing in your contexts during the early stages of the pandemic and response efforts – and what sources of information and data are you using to assess these impacts?
To what extent have assessment or consideration of indirect health effects informed decision-making around the COVID-19 response strategy to date? How do you see indirect health effects factoring into decision-making and priority setting for health as the COVID response continues?
What strategies or adaptations have been explored to try and minimize disruptions to essential health services, and what does or does not seem to be working? Are those strategies costed, and how are those strategies financed?
Dr. Kalipso Chalkidou, Director of Global Health Policy and a Senior Fellow at the Center for Global Development.
Dr. Y-Ling Chi, Senior Policy Analyst, Center for Global Development, and Technical Facilitator with the JLN Efficiency Collaborative.
Dr. Carleigh Krubiner, Policy fellow at the Center for Global Development and a Technical Facilitator with the JLN Efficiency Collaborative.
Prof. Alex Broadbent, Dean of Faculty of the Humanities, Professor of Philosophy, and Director of Institute for the Future of Knowledge at the University of Johannesburg.
Dr. Shankar Prinja, Additional Professor of Health Economics at the PGIMER School of Public Health, Chandigarh, India. in the context of universal health coverage